Author

I. Anagnostopoulos

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Rosenwald· 2 shared K. Rajewsky· 2 shared W. Winkler· 2 shared A. Akalin· 1 shared A. Curti· 1 shared A. Gulino· 1 shared A. Heuser· 1 shared A. Pfaus· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Rosenwald

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A new type of transcriptional reprogramming by an IRF4 mutation in lymphoma

N. Schleussner, P. Cauchy, V. Franke, M. Giefing, O. Fornes, N. Vankadari, S. Assi, M. Costanza, M. A. Weniger, A. Akalin, I. Anagnostopoulos, T. Bukur, M. G. Casarotto, F. Damm, O. Daumke, , R. Grosschedl

This study identifies a mutation in IRF4 that alters DNA-binding specificity and gene regulation in lymphoma, leading to disease-specific gene up-regulation.

bioRxiv · Dec 29, 2022 · PreprintCancer Biology

Preclinical models of human multiple myeloma subgroups

W. Winkler, C. Farre Diaz, E. Blanc, H. Napieczynska, P. Langner, M. Werner, B. Walter, B. Wollert-Wulf, T. Yasuda, A. Heuser, D. Beule, S. Mathas, I. Anagnostopoulos, A. Rosenwald, K. Rajewsky, M. Janz

This study generates preclinical models of human multiple myeloma subgroups by inducing specific genetic alterations in mice, showing their resemblance to human disease.

bioRxiv · Aug 28, 2021 · PreprintCancer Biology

CD40 provides immune privilege to the bone marrow hematopoietic niche

B. Bassani, A. Gulino, P. Portararo, L. Botti, B. Cappetti, C. Chiodoni, N. Bolli, M. Ciciarello, K. Joehrens, I. Anagnostopoulos, I.-K. Na, A. Curti, C. Tripodo, M. P. Colombo, S. Sangaletti

This study shows that CD40 on bone marrow mesenchymal stem cells (BM-MSCs) promotes immune tolerance and prevents graft-versus-host disease by regulating Treg function and B-cell development.

bioRxiv · Aug 10, 2020 · PreprintImmunology